West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
417.83
+0.03 (0.01%)
Nov 17, 2026, 10:31 AM EST - Market open

WST Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, WST stock has a consensus rating of "Strong Buy" and an average price target of $471. The average 1-year stock price forecast is 12.73% higher than the current stock price, while the lowest is $340 (-18.63%) and the highest is $500 (+19.67%).

Price Target: $471 (+12.73%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$340$471$480$500
Change-18.63%+12.73%+14.88%+19.67%

Analyst Ratings

The average analyst rating for WST stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy111111121212
Buy233433
Hold122100
Sell100011
Strong Sell000000
Total151616171616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Buy
Maintains
$420 → $500
BuyMaintains$420 → $500+19.67%Oct 30, 2026
Evercore ISI
Evercore ISI
Buy
Maintains
$440 → $480
BuyMaintains$440 → $480+14.88%Oct 30, 2026
UBS
UBS
Buy
Maintains
$435 → $495
BuyMaintains$435 → $495+18.47%Oct 30, 2026
Citi
Citi
Buy
Reiterates
$412 → $494
BuyReiterates$412 → $494+18.23%Oct 30, 2026
Barclays
Barclays
Buy
Maintains
$440 → $500
BuyMaintains$440 → $500+19.67%Oct 30, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.42B
from 3.07B
Increased by 11.26%
Revenue Next Year
3.62B
from 3.42B
Increased by 5.92%
EPS This Year
9.46
from 7.29
Increased by 29.79%
EPS Next Year
10.39
from 9.46
Increased by 9.85%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.83B2.89B2.95B2.89B3.07B3.42B
Revenue Growth
31.89%1.95%2.18%-1.92%6.25%11.26%
Gross Profit
1.18B1.14B1.13B998.50M1.10B1.30B
Gross Margin
41.59%39.36%38.31%34.51%35.91%37.91%
Operating Income
768.60M763.80M706.20M593.60M638.70M798.57M
Net Income
661.80M585.90M593.40M492.70M493.70M666.22M
EPS
----7.299.46
EPS Growth
----8.00%29.79%
Forward PE
53.5534.8442.2345.9036.6944.16
Dividend / Share
0.690.730.770.810.850.95
Dividend Growth
6.15%5.80%5.48%5.20%4.94%11.51%
Free Cash Flow
----468.90M439.50M
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High3.4B
Avg3.4B
Low3.4B

Revenue Growth

Revenue Growth202620272028
High
12.2%
Avg
11.3%
Low
11.0%

EPS Forecast

EPS202620272028
High9.63
Avg9.46
Low9.40

EPS Growth

EPS Growth202620272028
High
32.0%
Avg
29.8%
Low
28.9%